-
Why waiving vaccine patents isn’t enough to end the pandemic
Experts say waiving patents won’t help poorer nations acquire the technical complexity of manufacturing coronavirus vaccines. Read more: https://wapo.st/3xwlTv3. Subscribe to The Washington Post on YouTube: https://wapo.st/2QOdcqK
Follow us:
Twitter: https://twitter.com/washingtonpost
Instagram: https://www.instagram.com/washingtonpost/
Facebook: https://www.facebook.com/washingtonpost/
published: 18 Jun 2021
-
Bill Gates: 'What could cause, in a single year, an excess of 10 million deaths?'
In an exclusive interview with STAT, Bill Gates talked about his fear of a global pandemic. Read more here - https://www.statnews.com/2018/04/30/bill-gates-vaccine-trump-meeting/
published: 30 Apr 2018
-
Antiviral Patents: How prepared are we to combat novel viral diseases
With the novel coronavirus spreading both fear and illness across the world, it is a worthwhile exercise to look at the patent landscape of antiviral vaccines. By analyzing both the quality and quantity of the patent portfolios of the world's leading manufacturers and researchers, it is possible to evaluate the companies and research institutes that are at the forefront of finding vaccines and cures for potentially deadly viral diseases.
Watch our webinar to learn more about:
The entire technology field and key players in antiviral vaccine market
Review of selected companies who have technologies related to coronavirus
Portfolio landscaping of global pharma leaders in this technology field
How PatentSight metrics evaluate the portfolio strength
published: 19 May 2022
-
Responding to the Push to Violate Vaccine Patents
In this episode of New Ideal Live, Ben Bayer interviews special guest Adam Mossoff (https://www.law.gmu.edu/faculty/directory/fulltime/mossoff_adam), intellectual property expert and professor of law at Antonin Scalia Law School at George Mason University, about President Biden’s recent support for waiving overseas patent protection for the Covid-19 vaccines developed by companies like Pfizer and Moderna.
Among the topics covered:
The Biden administration’s proposals to waive Covid vaccine patent protection by international institutions;
Why intellectual property has only encouraged the development and distribution of medical technology and how this is the function of intellectual property;
The likely consequences of waiving intellectual property rights for Covid vaccines;
How intellectu...
published: 12 May 2021
-
Nobel Laureate claims 'vaccinated people will die in 2 years': Fact check | Oneindia News
You may have come across a viral news item of Nobel laureate Luc Montagnier in which it is purported that the scientist claimed that whosoever took the Covid-19 vaccine will die in 2 years. If you have not come across it, then you can mark yourself safe from fake news.
#LucMontaigner #FakeNews #FactCheck
--------------------------------------------------------------------------------------------------------------
Oneindia News is a youth-driven channel that brings you stories that need your attention, are popular, informative, and entertaining. Follow and like us for thought-provoking & exclusive content...
Youtube: https://www.youtube.com/channel/UCqTa...
Like us on Facebook: https://www.facebook.com/oneindianews
Follow us on Instagram: https://www.instagram.com/oneindia_news
We ar...
published: 26 May 2021
-
Covid 19 related situational questions for Patent agent exam preparation
Hypothetical questions
#patentagent; #patentagentexam; #patentagentexamtraining; #patentagentexam2024; #vivavoce2024
published: 06 Mar 2022
-
Prescription Drug Patents Balancing Innovation, Access, and Affordability
Patents are an important driver of prescription drug innovation. Recently, manufacturer practices under the current patent system have come under scrutiny for blocking or delaying the entry of generic or biosimilar drugs into the market. The development of novel therapies plays a critical role in treating, and in some cases eradicating, debilitating and costly diseases. However, the high cost of prescription drugs continues to challenge patients and the health care system. The sale of biosimilar and generic drugs offers a promising opportunity to promote prescription drug affordability through competition. During this webinar, panelists explored the relationship between patents, prices, and patient access.
published: 20 May 2019
-
Press Conference on 2020 International Patent, Trademark and Design Filings via WIPO
In a virtual press conference, WIPO Director General Daren Tang and WIPO Chief Economist Carsten Fink brief reporters about international intellectual property filing activity in 2020.
International patent filings via WIPO continued to grow in 2020 despite the COVID-19 pandemic, increasing 4% to reach 275,900 applications – the highest number ever. The use of the international trademark system dipped, but only slightly – whereas demand for international protection of industrial designs via WIPO’s Hague System fell by 15% in 2020.
Press release:
https://www.wipo.int/pressroom/en/articles/2021/article_0002.html
#wipo #DirectorGeneral #IntellectualProperty #Statistics
published: 02 Mar 2021
-
Meet 17-Year-Old Avi Schiffmann Who Runs Coronavirus Tracking Website Used by 40+ Million Globally
A teenager's website tracking coronavirus has become one of the most vital resources for people seeking accurate and updated numbers on the pandemic. The URL is nCoV2019.live. We speak with 17-year-old Avi Schiffmann, a high school junior from Mercer Island outside Seattle, who started the site in late December, when coronavirus had not yet been detected outside of China. Now the site has been visited by tens of millions, from every country on Earth. It tracks deaths, numbers of cases locally and globally, and provides an interactive map, information on the disease, and a Twitter feed. The resource updates every minute or so, and pulls information from the World Health Organization, the Centers for Disease Control and elsewhere.
#DemocracyNow
Democracy Now! is an independent global new...
published: 17 Mar 2020
-
How mRNA Vaccines Revolutionized Medicine | CNBC Marathon
CNBC Marathon takes a look back at the development, implications and profits from the groundbreaking mRNA Covid vaccine.
More than 30 biotech and pharmaceutical companies around the world raced to develop a safe Covid-19 vaccine. The process moved quickly with several vaccine candidates entering late-stage trials in a matter of months. Pfizer and Moderna used a promising new technology called messenger RNA. Watch the video to learn why experts believe this vaccination method could be a game-changer for getting back to normal.
Scientists are hopeful that the mRNA technology used in the Moderna and Pfizer-BioNTech Covid vaccines could be a turning point in HIV vaccine development. Watch the video above to learn why mRNA technology seems so promising, how this research is funded and who ult...
published: 01 Sep 2022
5:36
Why waiving vaccine patents isn’t enough to end the pandemic
Experts say waiving patents won’t help poorer nations acquire the technical complexity of manufacturing coronavirus vaccines. Read more: https://wapo.st/3xwlTv3...
Experts say waiving patents won’t help poorer nations acquire the technical complexity of manufacturing coronavirus vaccines. Read more: https://wapo.st/3xwlTv3. Subscribe to The Washington Post on YouTube: https://wapo.st/2QOdcqK
Follow us:
Twitter: https://twitter.com/washingtonpost
Instagram: https://www.instagram.com/washingtonpost/
Facebook: https://www.facebook.com/washingtonpost/
https://wn.com/Why_Waiving_Vaccine_Patents_Isn’T_Enough_To_End_The_Pandemic
Experts say waiving patents won’t help poorer nations acquire the technical complexity of manufacturing coronavirus vaccines. Read more: https://wapo.st/3xwlTv3. Subscribe to The Washington Post on YouTube: https://wapo.st/2QOdcqK
Follow us:
Twitter: https://twitter.com/washingtonpost
Instagram: https://www.instagram.com/washingtonpost/
Facebook: https://www.facebook.com/washingtonpost/
- published: 18 Jun 2021
- views: 2555
1:32
Bill Gates: 'What could cause, in a single year, an excess of 10 million deaths?'
In an exclusive interview with STAT, Bill Gates talked about his fear of a global pandemic. Read more here - https://www.statnews.com/2018/04/30/bill-gates-vacc...
In an exclusive interview with STAT, Bill Gates talked about his fear of a global pandemic. Read more here - https://www.statnews.com/2018/04/30/bill-gates-vaccine-trump-meeting/
https://wn.com/Bill_Gates_'What_Could_Cause,_In_A_Single_Year,_An_Excess_Of_10_Million_Deaths_'
In an exclusive interview with STAT, Bill Gates talked about his fear of a global pandemic. Read more here - https://www.statnews.com/2018/04/30/bill-gates-vaccine-trump-meeting/
- published: 30 Apr 2018
- views: 687909
1:11:39
Antiviral Patents: How prepared are we to combat novel viral diseases
With the novel coronavirus spreading both fear and illness across the world, it is a worthwhile exercise to look at the patent landscape of antiviral vaccines. ...
With the novel coronavirus spreading both fear and illness across the world, it is a worthwhile exercise to look at the patent landscape of antiviral vaccines. By analyzing both the quality and quantity of the patent portfolios of the world's leading manufacturers and researchers, it is possible to evaluate the companies and research institutes that are at the forefront of finding vaccines and cures for potentially deadly viral diseases.
Watch our webinar to learn more about:
The entire technology field and key players in antiviral vaccine market
Review of selected companies who have technologies related to coronavirus
Portfolio landscaping of global pharma leaders in this technology field
How PatentSight metrics evaluate the portfolio strength
https://wn.com/Antiviral_Patents_How_Prepared_Are_We_To_Combat_Novel_Viral_Diseases
With the novel coronavirus spreading both fear and illness across the world, it is a worthwhile exercise to look at the patent landscape of antiviral vaccines. By analyzing both the quality and quantity of the patent portfolios of the world's leading manufacturers and researchers, it is possible to evaluate the companies and research institutes that are at the forefront of finding vaccines and cures for potentially deadly viral diseases.
Watch our webinar to learn more about:
The entire technology field and key players in antiviral vaccine market
Review of selected companies who have technologies related to coronavirus
Portfolio landscaping of global pharma leaders in this technology field
How PatentSight metrics evaluate the portfolio strength
- published: 19 May 2022
- views: 43
1:11:30
Responding to the Push to Violate Vaccine Patents
In this episode of New Ideal Live, Ben Bayer interviews special guest Adam Mossoff (https://www.law.gmu.edu/faculty/directory/fulltime/mossoff_adam), intellectu...
In this episode of New Ideal Live, Ben Bayer interviews special guest Adam Mossoff (https://www.law.gmu.edu/faculty/directory/fulltime/mossoff_adam), intellectual property expert and professor of law at Antonin Scalia Law School at George Mason University, about President Biden’s recent support for waiving overseas patent protection for the Covid-19 vaccines developed by companies like Pfizer and Moderna.
Among the topics covered:
The Biden administration’s proposals to waive Covid vaccine patent protection by international institutions;
Why intellectual property has only encouraged the development and distribution of medical technology and how this is the function of intellectual property;
The likely consequences of waiving intellectual property rights for Covid vaccines;
How intellectual property rights made possible the creation of the Covid vaccines and treatments;
Why intellectual property rights are not fundamentally justified by their contribution to the “public good” but by the principle of individual rights;
Whether the government acquires rights to intellectual property by investing in the development of innovations;
Whether Section 1498 of the U.S. Code allows for government to exercise eminent domain over vaccine patents;
Whether intellectual property rights allow pharmaceutical companies to profit from the spread of disease;
Changes to the legal system and trade policy that would allow better production and distribution of the vaccines overseas;
How a biological product can be considered intellectual property;
The role of intellectual property in the development of a malaria vaccine and other mRNA vaccines.
Mentioned in the discussion are
Ayn Rand’s essay “Patents and Copyrights,” (https://courses.aynrand.org/works/patents-and-copyrights/) Adam Mossoff’s article “Waiving Vaccine Patents Would Imperil Public Health,” (https://www.pilotonline.com/opinion/columns/vp-ed-column-mossoff-0414-20210413-krqhjk7zhfgyxjm4kyvjivitym-story.html) and Ben Bayer’s article “The Unscientific, Un-American Ethics of Vaccine Distribution.” (https://newideal.aynrand.org/the-unscientific-un-american-ethics-of-vaccine-distribution/)
0:00:00 Introduction
0:01:38 Proposals to violate vaccine patents
0:10:12 Patents encourage vaccine innovation
0:14:43 Likely results of violating patents
0:22:14 How patents helped Covid-19 vaccines
0:25:39 Individual rights, not "public good"
0:31:50 Does investment create patent rights?
0:42:22 Section 1498 and eminent domain
0:48:05 Does Pharma profit from disease?
0:53:42 Changes needed for overseas vaccines
0:58:33 Biological products: patentable?
1:04:08 Malaria and other mRNA vaccines
https://wn.com/Responding_To_The_Push_To_Violate_Vaccine_Patents
In this episode of New Ideal Live, Ben Bayer interviews special guest Adam Mossoff (https://www.law.gmu.edu/faculty/directory/fulltime/mossoff_adam), intellectual property expert and professor of law at Antonin Scalia Law School at George Mason University, about President Biden’s recent support for waiving overseas patent protection for the Covid-19 vaccines developed by companies like Pfizer and Moderna.
Among the topics covered:
The Biden administration’s proposals to waive Covid vaccine patent protection by international institutions;
Why intellectual property has only encouraged the development and distribution of medical technology and how this is the function of intellectual property;
The likely consequences of waiving intellectual property rights for Covid vaccines;
How intellectual property rights made possible the creation of the Covid vaccines and treatments;
Why intellectual property rights are not fundamentally justified by their contribution to the “public good” but by the principle of individual rights;
Whether the government acquires rights to intellectual property by investing in the development of innovations;
Whether Section 1498 of the U.S. Code allows for government to exercise eminent domain over vaccine patents;
Whether intellectual property rights allow pharmaceutical companies to profit from the spread of disease;
Changes to the legal system and trade policy that would allow better production and distribution of the vaccines overseas;
How a biological product can be considered intellectual property;
The role of intellectual property in the development of a malaria vaccine and other mRNA vaccines.
Mentioned in the discussion are
Ayn Rand’s essay “Patents and Copyrights,” (https://courses.aynrand.org/works/patents-and-copyrights/) Adam Mossoff’s article “Waiving Vaccine Patents Would Imperil Public Health,” (https://www.pilotonline.com/opinion/columns/vp-ed-column-mossoff-0414-20210413-krqhjk7zhfgyxjm4kyvjivitym-story.html) and Ben Bayer’s article “The Unscientific, Un-American Ethics of Vaccine Distribution.” (https://newideal.aynrand.org/the-unscientific-un-american-ethics-of-vaccine-distribution/)
0:00:00 Introduction
0:01:38 Proposals to violate vaccine patents
0:10:12 Patents encourage vaccine innovation
0:14:43 Likely results of violating patents
0:22:14 How patents helped Covid-19 vaccines
0:25:39 Individual rights, not "public good"
0:31:50 Does investment create patent rights?
0:42:22 Section 1498 and eminent domain
0:48:05 Does Pharma profit from disease?
0:53:42 Changes needed for overseas vaccines
0:58:33 Biological products: patentable?
1:04:08 Malaria and other mRNA vaccines
- published: 12 May 2021
- views: 1108
1:53
Nobel Laureate claims 'vaccinated people will die in 2 years': Fact check | Oneindia News
You may have come across a viral news item of Nobel laureate Luc Montagnier in which it is purported that the scientist claimed that whosoever took the Covid-19...
You may have come across a viral news item of Nobel laureate Luc Montagnier in which it is purported that the scientist claimed that whosoever took the Covid-19 vaccine will die in 2 years. If you have not come across it, then you can mark yourself safe from fake news.
#LucMontaigner #FakeNews #FactCheck
--------------------------------------------------------------------------------------------------------------
Oneindia News is a youth-driven channel that brings you stories that need your attention, are popular, informative, and entertaining. Follow and like us for thought-provoking & exclusive content...
Youtube: https://www.youtube.com/channel/UCqTa...
Like us on Facebook: https://www.facebook.com/oneindianews
Follow us on Instagram: https://www.instagram.com/oneindia_news
We are there on Twitter: https://twitter.com/Oneindia
https://wn.com/Nobel_Laureate_Claims_'Vaccinated_People_Will_Die_In_2_Years'_Fact_Check_|_Oneindia_News
You may have come across a viral news item of Nobel laureate Luc Montagnier in which it is purported that the scientist claimed that whosoever took the Covid-19 vaccine will die in 2 years. If you have not come across it, then you can mark yourself safe from fake news.
#LucMontaigner #FakeNews #FactCheck
--------------------------------------------------------------------------------------------------------------
Oneindia News is a youth-driven channel that brings you stories that need your attention, are popular, informative, and entertaining. Follow and like us for thought-provoking & exclusive content...
Youtube: https://www.youtube.com/channel/UCqTa...
Like us on Facebook: https://www.facebook.com/oneindianews
Follow us on Instagram: https://www.instagram.com/oneindia_news
We are there on Twitter: https://twitter.com/Oneindia
- published: 26 May 2021
- views: 6141729
1:02:10
Covid 19 related situational questions for Patent agent exam preparation
Hypothetical questions
#patentagent; #patentagentexam; #patentagentexamtraining; #patentagentexam2024; #vivavoce2024
Hypothetical questions
#patentagent; #patentagentexam; #patentagentexamtraining; #patentagentexam2024; #vivavoce2024
https://wn.com/Covid_19_Related_Situational_Questions_For_Patent_Agent_Exam_Preparation
Hypothetical questions
#patentagent; #patentagentexam; #patentagentexamtraining; #patentagentexam2024; #vivavoce2024
- published: 06 Mar 2022
- views: 1138
1:14:41
Prescription Drug Patents Balancing Innovation, Access, and Affordability
Patents are an important driver of prescription drug innovation. Recently, manufacturer practices under the current patent system have come under scrutiny for b...
Patents are an important driver of prescription drug innovation. Recently, manufacturer practices under the current patent system have come under scrutiny for blocking or delaying the entry of generic or biosimilar drugs into the market. The development of novel therapies plays a critical role in treating, and in some cases eradicating, debilitating and costly diseases. However, the high cost of prescription drugs continues to challenge patients and the health care system. The sale of biosimilar and generic drugs offers a promising opportunity to promote prescription drug affordability through competition. During this webinar, panelists explored the relationship between patents, prices, and patient access.
https://wn.com/Prescription_Drug_Patents_Balancing_Innovation,_Access,_And_Affordability
Patents are an important driver of prescription drug innovation. Recently, manufacturer practices under the current patent system have come under scrutiny for blocking or delaying the entry of generic or biosimilar drugs into the market. The development of novel therapies plays a critical role in treating, and in some cases eradicating, debilitating and costly diseases. However, the high cost of prescription drugs continues to challenge patients and the health care system. The sale of biosimilar and generic drugs offers a promising opportunity to promote prescription drug affordability through competition. During this webinar, panelists explored the relationship between patents, prices, and patient access.
- published: 20 May 2019
- views: 532
41:48
Press Conference on 2020 International Patent, Trademark and Design Filings via WIPO
In a virtual press conference, WIPO Director General Daren Tang and WIPO Chief Economist Carsten Fink brief reporters about international intellectual property ...
In a virtual press conference, WIPO Director General Daren Tang and WIPO Chief Economist Carsten Fink brief reporters about international intellectual property filing activity in 2020.
International patent filings via WIPO continued to grow in 2020 despite the COVID-19 pandemic, increasing 4% to reach 275,900 applications – the highest number ever. The use of the international trademark system dipped, but only slightly – whereas demand for international protection of industrial designs via WIPO’s Hague System fell by 15% in 2020.
Press release:
https://www.wipo.int/pressroom/en/articles/2021/article_0002.html
#wipo #DirectorGeneral #IntellectualProperty #Statistics
https://wn.com/Press_Conference_On_2020_International_Patent,_Trademark_And_Design_Filings_Via_Wipo
In a virtual press conference, WIPO Director General Daren Tang and WIPO Chief Economist Carsten Fink brief reporters about international intellectual property filing activity in 2020.
International patent filings via WIPO continued to grow in 2020 despite the COVID-19 pandemic, increasing 4% to reach 275,900 applications – the highest number ever. The use of the international trademark system dipped, but only slightly – whereas demand for international protection of industrial designs via WIPO’s Hague System fell by 15% in 2020.
Press release:
https://www.wipo.int/pressroom/en/articles/2021/article_0002.html
#wipo #DirectorGeneral #IntellectualProperty #Statistics
- published: 02 Mar 2021
- views: 1303
14:02
Meet 17-Year-Old Avi Schiffmann Who Runs Coronavirus Tracking Website Used by 40+ Million Globally
A teenager's website tracking coronavirus has become one of the most vital resources for people seeking accurate and updated numbers on the pandemic. The URL is...
A teenager's website tracking coronavirus has become one of the most vital resources for people seeking accurate and updated numbers on the pandemic. The URL is nCoV2019.live. We speak with 17-year-old Avi Schiffmann, a high school junior from Mercer Island outside Seattle, who started the site in late December, when coronavirus had not yet been detected outside of China. Now the site has been visited by tens of millions, from every country on Earth. It tracks deaths, numbers of cases locally and globally, and provides an interactive map, information on the disease, and a Twitter feed. The resource updates every minute or so, and pulls information from the World Health Organization, the Centers for Disease Control and elsewhere.
#DemocracyNow
Democracy Now! is an independent global news hour that airs on nearly 1,400 TV and radio stations Monday through Friday. Watch our livestream 8-9AM ET: https://democracynow.org
Please consider supporting independent media by making a donation to Democracy Now! today: https://democracynow.org/donate
FOLLOW DEMOCRACY NOW! ONLINE:
YouTube: http://youtube.com/democracynow
Facebook: http://facebook.com/democracynow
Twitter: https://twitter.com/democracynow
Instagram: http://instagram.com/democracynow
SoundCloud: http://soundcloud.com/democracynow
iTunes: https://itunes.apple.com/podcast/democracy-now!-audio/id73802554
Daily Email Digest: https://democracynow.org/subscribe
https://wn.com/Meet_17_Year_Old_Avi_Schiffmann_Who_Runs_Coronavirus_Tracking_Website_Used_By_40_Million_Globally
A teenager's website tracking coronavirus has become one of the most vital resources for people seeking accurate and updated numbers on the pandemic. The URL is nCoV2019.live. We speak with 17-year-old Avi Schiffmann, a high school junior from Mercer Island outside Seattle, who started the site in late December, when coronavirus had not yet been detected outside of China. Now the site has been visited by tens of millions, from every country on Earth. It tracks deaths, numbers of cases locally and globally, and provides an interactive map, information on the disease, and a Twitter feed. The resource updates every minute or so, and pulls information from the World Health Organization, the Centers for Disease Control and elsewhere.
#DemocracyNow
Democracy Now! is an independent global news hour that airs on nearly 1,400 TV and radio stations Monday through Friday. Watch our livestream 8-9AM ET: https://democracynow.org
Please consider supporting independent media by making a donation to Democracy Now! today: https://democracynow.org/donate
FOLLOW DEMOCRACY NOW! ONLINE:
YouTube: http://youtube.com/democracynow
Facebook: http://facebook.com/democracynow
Twitter: https://twitter.com/democracynow
Instagram: http://instagram.com/democracynow
SoundCloud: http://soundcloud.com/democracynow
iTunes: https://itunes.apple.com/podcast/democracy-now!-audio/id73802554
Daily Email Digest: https://democracynow.org/subscribe
- published: 17 Mar 2020
- views: 334467
42:40
How mRNA Vaccines Revolutionized Medicine | CNBC Marathon
CNBC Marathon takes a look back at the development, implications and profits from the groundbreaking mRNA Covid vaccine.
More than 30 biotech and pharmaceutica...
CNBC Marathon takes a look back at the development, implications and profits from the groundbreaking mRNA Covid vaccine.
More than 30 biotech and pharmaceutical companies around the world raced to develop a safe Covid-19 vaccine. The process moved quickly with several vaccine candidates entering late-stage trials in a matter of months. Pfizer and Moderna used a promising new technology called messenger RNA. Watch the video to learn why experts believe this vaccination method could be a game-changer for getting back to normal.
Scientists are hopeful that the mRNA technology used in the Moderna and Pfizer-BioNTech Covid vaccines could be a turning point in HIV vaccine development. Watch the video above to learn why mRNA technology seems so promising, how this research is funded and who ultimately makes the money once a vaccine is ready to go to market.
And it's been well over a year since a landmark proposal brought the issue of patent waiver for the mRNA Covid vaccine to the spotlight. But many observers don't see waiving the intellectual property (IP) rights on Covid vaccines as an effective way to put a stop to the pandemic. Watch the video to find out more about why vaccine patents exist and the ongoing debate over their impact on the Covid pandemic.
CNBC Marathon brings together the best of CNBC’s coverage on how mRNA revolutionized vaccines in America.
Chapters:
00:00 Introduction
00:43 What is an mRNA Coronavirus vaccine? (Published Sept. 2020)
17:54 What does the success of the Covid mRNA vaccines mean for HIV? (Published Dec. 2021)
31:12 Who owns the mRNA Covid vaccine? (Published Jan. 2022)
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Connect with CNBC News Online
Get the latest news: https://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
#CNBC
How mRNA Vaccines Revolutionized Medicine | CNBC Marathon
https://wn.com/How_Mrna_Vaccines_Revolutionized_Medicine_|_Cnbc_Marathon
CNBC Marathon takes a look back at the development, implications and profits from the groundbreaking mRNA Covid vaccine.
More than 30 biotech and pharmaceutical companies around the world raced to develop a safe Covid-19 vaccine. The process moved quickly with several vaccine candidates entering late-stage trials in a matter of months. Pfizer and Moderna used a promising new technology called messenger RNA. Watch the video to learn why experts believe this vaccination method could be a game-changer for getting back to normal.
Scientists are hopeful that the mRNA technology used in the Moderna and Pfizer-BioNTech Covid vaccines could be a turning point in HIV vaccine development. Watch the video above to learn why mRNA technology seems so promising, how this research is funded and who ultimately makes the money once a vaccine is ready to go to market.
And it's been well over a year since a landmark proposal brought the issue of patent waiver for the mRNA Covid vaccine to the spotlight. But many observers don't see waiving the intellectual property (IP) rights on Covid vaccines as an effective way to put a stop to the pandemic. Watch the video to find out more about why vaccine patents exist and the ongoing debate over their impact on the Covid pandemic.
CNBC Marathon brings together the best of CNBC’s coverage on how mRNA revolutionized vaccines in America.
Chapters:
00:00 Introduction
00:43 What is an mRNA Coronavirus vaccine? (Published Sept. 2020)
17:54 What does the success of the Covid mRNA vaccines mean for HIV? (Published Dec. 2021)
31:12 Who owns the mRNA Covid vaccine? (Published Jan. 2022)
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Connect with CNBC News Online
Get the latest news: https://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
#CNBC
How mRNA Vaccines Revolutionized Medicine | CNBC Marathon
- published: 01 Sep 2022
- views: 56152